Evidence map›Paper›PMID 7568005›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America1995

Critical role of the interleukin 2 (IL-2) receptor gamma-chain-associated Jak3 in the IL-2-induced c-fos and c-myc, but not bcl-2, gene induction.

A Kawahara, Y Minami, T Miyazaki, J N Ihle, T Taniguchi

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 1995. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
6.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 107 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. The Common Cytokine Receptor γ Chain Family of Cytokines.Cold Spring Harbor perspectives in biology · 2018
    Review
  5. Article
  6. Article
  7. Article
  8. Differential requirement of the cytoplasmic subregions of gamma c chain in T cell development and function.Proceedings of the National Academy of Sciences of the United States of America · 2000
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Cytokine-induced survival of activated T cells in vitro and in vivo.Proceedings of the National Academy of Sciences of the United States of America · 1998
    Article
  17. Article
  18. The hyper-IgM (HIM) syndrome.Springer seminars in immunopathology · 1998
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 3 countries.

A KawaharaInstitute of Molecular and Cellular Biology, Osaka University, Japan.
Y Minami
T Miyazaki
J N Ihle
T Taniguchi
Osaka University · JPBoehringer Ingelheim (Japan) · JPResearch Institute of Molecular Pathology · ATSt. Jude Children's Research Hospital · US

Funding

Viral Vector Technology (VVTSR)P30CA021765 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI CHARLES ROBERTS · 1985 to 2026
$166.9M
INTERLEUKIN-3 REGULATED GROWTH OF HEMATOPOIETIC CELLSR01DK042932 · NIDDK · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI IHLE, JAMES N · 1990 to 2007
$2.5M
NCI NIH HHS P30 CA21765NIDDK NIH HHS R01 DK42932
6 · The paper itself

Abstract

The interleukin 2 receptor (IL-2R) consists of three subunits, the IL-2R alpha, IL-2R beta c, and IL-2R gamma c chains. Two Janus family protein tyrosine kinases (PTKs), Jak1 and Jak3, were shown to associate with IL-2R beta c and IL-2R gamma c, respectively, and their PTK activities are increased after IL-2 stimulation. A Jak3 mutant with truncation of the C-terminal PTK domain lacks its intrinsic kinase activity but can still associate with IL-2R gamma c. In a hematopoietic cell line, F7, that responds to either IL-2 or IL-3, overexpression of this Jak3 mutant results in selective inhibition of the IL-2-induced activation of Jak1/Jak3 PTKs and of cell proliferation. Of the three target nuclear protooncogenes of the IL-2 signaling, c-fos and c-myc genes, but not the bcl-2 gene, were found to be impaired. On the other hand, overexpression of the dominant negative form of the IL-2R gamma c chain, which lacks most of its cytoplasmic domain, in F7 cells resulted in the inhibition of all three protooncogenes. These results provide a further molecular basis for the critical role of Jak3 in IL-2 signaling and also suggest a Jak PTK-independent signaling pathway(s) for the bcl-2 gene induction by IL-2R.

Indexed as

Gene Expression RegulationSignal TransductionAnimalsCell DivisionCell LineHematopoietic Stem CellsHumansInterleukin-2Janus Kinase 3MiceMutationPromoter Regions, GeneticProtein-Tyrosine KinasesProto-Oncogene ProteinsProto-Oncogene Proteins c-bcl-2Proto-Oncogene Proteins c-fosInterleukin-2JAK3 protein, humanJak3 protein, mouseJanus Kinase 3Protein-Tyrosine KinasesProto-Oncogene ProteinsProto-Oncogene Proteins c-bcl-2Proto-Oncogene Proteins c-fosProto-Oncogene Proteins c-mycReceptors, Interleukin-2

Identifiers

PMID7568005
PMCPMC41039
OpenAlexW2039940527

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.